Here is a comprehensive overview of drugs that increase intracranial pressure (ICP), organized by mechanism:
Drugs That Increase Intracranial Pressure (ICP)
1. Volatile (Inhalational) Anesthetics
Halothane, Isoflurane, Sevoflurane, Desflurane, Enflurane
- Cause cerebral vasodilation → ↑ cerebral blood flow (CBF) → ↑ ICP, particularly at higher concentrations (≥1.5 MAC)
- At 0.5 MAC, the reduction in cerebral metabolic rate (CMR) exceeds vasodilation, so CBF may decrease. At 1.5 MAC, vasodilation dominates and CBF increases
- This effect is most clinically relevant in patients with brain tumors, intracranial hemorrhage, or head injury
- Hyperventilation (↓ PaCO₂ → cerebral vasoconstriction) can attenuate this effect
Katzung's Basic and Clinical Pharmacology, 16e; Barash Clinical Anesthesia, 9e
2. Nitrous Oxide (N₂O)
- Increases CBF and ICP via sympathetic nervous system activation
- Produces mild elevation of ICP and also increases cerebral oxygen consumption (CMRO₂)
- Can be mitigated by combining with IV anesthetics or hyperventilation
Katzung's Basic and Clinical Pharmacology, 16e; Morgan & Mikhail's Clinical Anesthesiology, 7e
3. Ketamine
- Traditionally considered to increase cerebral oxygen consumption, CBF, and ICP through NMDA receptor activation and sympathetic stimulation
- However, modern evidence suggests that when combined with benzodiazepines and controlled ventilation (excluding N₂O), ketamine does not consistently raise ICP
- Still used cautiously or avoided as a solo agent in patients with intracranial hypertension
Morgan & Mikhail's Clinical Anesthesiology, 7e; Tintinalli's Emergency Medicine
4. Succinylcholine (Suxamethonium)
- The depolarizing muscle relaxant can transiently increase ICP
- Mechanism: muscle fasciculations stimulate muscle stretch receptors → activation of cerebral activity → modest ↑ CBF and ICP
- Can be attenuated by pre-treatment with a non-depolarizing neuromuscular blocking drug (defasciculation dose) and by maintaining airway control with hyperventilation
Morgan & Mikhail's Clinical Anesthesiology, 7e; Miller's Anesthesia, 10e
5. Drug-Induced Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
These drugs cause secondary pseudotumor cerebri — raised ICP without a structural cause:
| Drug Class | Examples |
|---|
| Tetracycline antibiotics | Tetracycline, minocycline, doxycycline |
| Fluoroquinolones | Ciprofloxacin, others |
| Vitamin A and retinoids | Isotretinoin (Accutane), vitamin A excess, all-trans retinoic acid |
| Lithium | Used in bipolar disorder |
| Growth hormone | Exogenous GH therapy |
| Corticosteroids (withdrawal) | Rapid withdrawal after prolonged use |
Goldman-Cecil Medicine, 2e
6. Other Anesthesia-Related Mechanisms
- Airway stimulation / inadequate anesthesia during intubation: Causes EEG activation, ↑ CMR, ↑ CBF → ↑ ICP (especially in patients with decreased intracranial compliance)
- Sedatives causing cerebral vasodilation: e.g., high-dose benzodiazepines, though generally ICP-neutral or reducing at clinical doses
Key Concept: Monro-Kellie Doctrine
Any drug that increases the volume of one intracranial compartment (brain, blood, CSF) — particularly by increasing CBF or cerebral blood volume — will raise ICP when intracranial compliance is reduced.
Clinical Takeaway
| Category | Drugs |
|---|
| Volatile anesthetics (dose-dependent) | Halothane > Isoflurane, Sevoflurane, Desflurane |
| Inhaled agents | Nitrous oxide |
| IV induction agents | Ketamine (traditional view; context-dependent) |
| Depolarizing NMBDs | Succinylcholine |
| Drug-induced pseudotumor | Tetracyclines, retinoids (isotretinoin), fluoroquinolones, lithium, growth hormone, corticosteroid withdrawal |